# NU Skin Enterprises, Inc.: financial statements, quarterly

NUS · NYSE · CIK 1021561 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nus.md) · [Financials](/companies/nus/financials.md) · [Filings](/companies/nus/filings.md) · [Insiders](/companies/nus/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nus/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [499](/filings/0001140361-24-045720.md) | [489 d](/filings/0001140361-26-005130.md) | [417](/filings/0001140361-25-018024.md) | [439](/filings/0001140361-25-029673.md) | [430](/filings/0001140361-25-040839.md) | [446 d](/filings/0001140361-26-005130.md) | [364](/filings/0001140361-26-019630.md) | [386](/filings/0001140361-26-032055.md) | [364](/filings/0001140361-25-040839.md) | [370 d](/filings/0001140361-26-005130.md) | [321](/filings/0001140361-26-019630.md) | [320](/filings/0001140361-26-032055.md) |
| Cost of revenue | $m | [207](/filings/0001140361-24-045720.md) | [136 d](/filings/0001140361-26-005130.md) | [123](/filings/0001140361-25-018024.md) | [132](/filings/0001140361-25-029673.md) | [129](/filings/0001140361-25-040839.md) | [166 d](/filings/0001140361-26-005130.md) | [118](/filings/0001140361-26-019630.md) | [120](/filings/0001140361-26-032055.md) | [107](/filings/0001140361-25-040839.md) | [108 d](/filings/0001140361-26-005130.md) | [106](/filings/0001140361-26-019630.md) | [102](/filings/0001140361-26-032055.md) |
| Gross profit | $m | [292](/filings/0001140361-24-045720.md) | [352 d](/filings/0001140361-26-005130.md) | [294](/filings/0001140361-25-018024.md) | [307](/filings/0001140361-25-029673.md) | [301](/filings/0001140361-25-040839.md) | [279 d](/filings/0001140361-26-005130.md) | [247](/filings/0001140361-26-019630.md) | [266](/filings/0001140361-26-032055.md) | [257](/filings/0001140361-25-040839.md) | [262 d](/filings/0001140361-26-005130.md) | [214](/filings/0001140361-26-019630.md) | [218](/filings/0001140361-26-032055.md) |
| Operating income | $m | [(26.4)](/filings/0001140361-24-045720.md) | [16.1 d](/filings/0001140361-26-005130.md) | [8.8](/filings/0001140361-25-018024.md) | [(126)](/filings/0001140361-25-029673.md) | [18.2](/filings/0001140361-25-040839.md) | [(53.1) d](/filings/0001140361-26-005130.md) | [(9.9)](/filings/0001140361-26-019630.md) | [30.8](/filings/0001140361-26-032055.md) | [21.6](/filings/0001140361-25-040839.md) | [23.2 d](/filings/0001140361-26-005130.md) | [4.0](/filings/0001140361-26-019630.md) | [(59.3)](/filings/0001140361-26-032055.md) |
| Interest expense | $m | [7.5](/filings/0001140361-24-045720.md) | [7.4 d](/filings/0001140361-24-008111.md) | [7.3](/filings/0001140361-24-025012.md) | [6.7](/filings/0001140361-24-036467.md) | [6.5](/filings/0001140361-24-045720.md) | [5.9 d](/filings/0001140361-26-005130.md) | [3.3](/filings/0001140361-26-019630.md) | [2.5](/filings/0001140361-26-032055.md) | [4.1](/filings/0001140361-25-040839.md) | [4.0 d](/filings/0001140361-26-005130.md) | [4.3](/filings/0001140361-26-019630.md) | [3.3](/filings/0001140361-26-032055.md) |
| Income tax | $m | [2.5](/filings/0001140361-24-045720.md) | [2.0 d](/filings/0001140361-26-005130.md) | [1.6](/filings/0001140361-25-018024.md) | [(13.4)](/filings/0001140361-25-029673.md) | [5.0](/filings/0001140361-25-040839.md) | [(21.7) d](/filings/0001140361-26-005130.md) | [27.1](/filings/0001140361-26-019630.md) | [6.3](/filings/0001140361-26-032055.md) | [(1.1)](/filings/0001140361-25-040839.md) | [3.7 d](/filings/0001140361-26-005130.md) | [0.8](/filings/0001140361-26-019630.md) | [187](/filings/0001140361-26-032055.md) |
| Net income | $m | [(37.0)](/filings/0001140361-24-045720.md) | [7.3 d](/filings/0001140361-26-005130.md) | [(0.5)](/filings/0001140361-25-018024.md) | [(118)](/filings/0001140361-25-029673.md) | [8.3](/filings/0001140361-25-040839.md) | [(36.1) d](/filings/0001140361-26-005130.md) | [108](/filings/0001140361-26-019630.md) | [21.1](/filings/0001140361-26-032055.md) | [17.1](/filings/0001140361-25-040839.md) | [14.5 d](/filings/0001140361-26-005130.md) | [1.8](/filings/0001140361-26-019630.md) | [(250)](/filings/0001140361-26-032055.md) |
| Diluted EPS | $ per share | [(0.74)](/filings/0001140361-24-045720.md) | not reported | [(0.01)](/filings/0001140361-25-018024.md) | [(2.38)](/filings/0001140361-25-029673.md) | [0.17](/filings/0001140361-25-040839.md) | not reported | [2.14](/filings/0001140361-26-019630.md) | [0.43](/filings/0001140361-26-032055.md) | [0.34](/filings/0001140361-25-040839.md) | not reported | [0.04](/filings/0001140361-26-019630.md) | [(5.14)](/filings/0001140361-26-032055.md) |
| Basic EPS | $ per share | [(0.74)](/filings/0001140361-24-045720.md) | not reported | [(0.01)](/filings/0001140361-25-018024.md) | [(2.38)](/filings/0001140361-25-029673.md) | [0.17](/filings/0001140361-25-040839.md) | not reported | [2.16](/filings/0001140361-26-019630.md) | [0.43](/filings/0001140361-26-032055.md) | [0.35](/filings/0001140361-25-040839.md) | not reported | [0.04](/filings/0001140361-26-019630.md) | [(5.14)](/filings/0001140361-26-032055.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [233](/filings/0001140361-23-050921.md) | [256](/filings/0001140361-25-004907.md) | [213](/filings/0001140361-24-025012.md) | [224](/filings/0001140361-24-036467.md) | [228](/filings/0001140361-24-045720.md) | [187](/filings/0001140361-26-005130.md) | [204](/filings/0001140361-25-018024.md) | [264](/filings/0001140361-25-029673.md) | [252](/filings/0001140361-25-040839.md) | [239](/filings/0001140361-26-032055.md) | [199](/filings/0001140361-26-019630.md) | [190](/filings/0001140361-26-032055.md) |
| Current assets | $m | [701](/filings/0001140361-23-050921.md) | [702](/filings/0001140361-25-004907.md) | [647](/filings/0001140361-24-025012.md) | [654](/filings/0001140361-24-036467.md) | [653](/filings/0001140361-24-045720.md) | [539](/filings/0001140361-26-005130.md) | [525](/filings/0001140361-25-018024.md) | [572](/filings/0001140361-25-029673.md) | [548](/filings/0001140361-25-040839.md) | [548](/filings/0001140361-26-032055.md) | [523](/filings/0001140361-26-019630.md) | [508](/filings/0001140361-26-032055.md) |
| Total assets | $m | [1,793](/filings/0001140361-23-050921.md) | [1,809](/filings/0001140361-25-004907.md) | [1,742](/filings/0001140361-24-025012.md) | [1,586](/filings/0001140361-24-036467.md) | [1,583](/filings/0001140361-24-045720.md) | [1,469](/filings/0001140361-26-005130.md) | [1,391](/filings/0001140361-25-018024.md) | [1,444](/filings/0001140361-25-029673.md) | [1,424](/filings/0001140361-25-040839.md) | [1,405](/filings/0001140361-26-032055.md) | [1,377](/filings/0001140361-26-019630.md) | [1,122](/filings/0001140361-26-032055.md) |
| Current liabilities | $m | [434](/filings/0001140361-23-050921.md) | [329](/filings/0001140361-25-004907.md) | [309](/filings/0001140361-24-025012.md) | [309](/filings/0001140361-24-036467.md) | [339](/filings/0001140361-24-045720.md) | [297](/filings/0001140361-26-005130.md) | [260](/filings/0001140361-25-018024.md) | [284](/filings/0001140361-25-029673.md) | [254](/filings/0001140361-25-040839.md) | [264](/filings/0001140361-26-032055.md) | [257](/filings/0001140361-26-019630.md) | [256](/filings/0001140361-26-032055.md) |
| Total liabilities | $m | [971](/filings/0001140361-23-050921.md) | [987](/filings/0001140361-25-004907.md) | [932](/filings/0001140361-24-025012.md) | [900](/filings/0001140361-24-036467.md) | [876](/filings/0001140361-24-045720.md) | [817](/filings/0001140361-26-005130.md) | [637](/filings/0001140361-25-018024.md) | [656](/filings/0001140361-25-029673.md) | [625](/filings/0001140361-25-040839.md) | [600](/filings/0001140361-26-032055.md) | [583](/filings/0001140361-26-019630.md) | [579](/filings/0001140361-26-032055.md) |
| Long-term debt | $m | [363](/filings/0001140361-23-050921.md) | [478](/filings/0001140361-25-004907.md) | [453](/filings/0001140361-24-025012.md) | [428](/filings/0001140361-24-036467.md) | [373](/filings/0001140361-24-045720.md) | [364](/filings/0001140361-26-005130.md) | [219](/filings/0001140361-25-018024.md) | [214](/filings/0001140361-25-029673.md) | [209](/filings/0001140361-25-040839.md) | [204](/filings/0001140361-26-032055.md) | [204](/filings/0001140361-26-019630.md) | [194](/filings/0001140361-26-032055.md) |
| Current portion of debt | $m | [140](/filings/0001140361-23-050921.md) | [25.0](/filings/0001140361-25-004907.md) | [30.0](/filings/0001140361-24-025012.md) | [30.0](/filings/0001140361-24-036467.md) | [60.0](/filings/0001140361-24-045720.md) | [30.0](/filings/0001140361-26-005130.md) | [20.0](/filings/0001140361-25-018024.md) | [35.0](/filings/0001140361-25-029673.md) | [20.0](/filings/0001140361-25-040839.md) | [20.0](/filings/0001140361-26-032055.md) | [20.0](/filings/0001140361-26-019630.md) | [20.0](/filings/0001140361-26-032055.md) |
| Shareholders' equity | $m | [822](/filings/0001140361-23-050921.md) | [822](/filings/0001140361-25-004907.md) | [810](/filings/0001140361-24-025012.md) | [686](/filings/0001140361-24-036467.md) | [707](/filings/0001140361-24-045720.md) | [651](/filings/0001140361-26-005130.md) | [754](/filings/0001140361-25-018024.md) | [788](/filings/0001140361-25-029673.md) | [800](/filings/0001140361-25-040839.md) | [805](/filings/0001140361-26-032055.md) | [794](/filings/0001140361-26-019630.md) | [543](/filings/0001140361-26-032055.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [51.0 d](/filings/0001140361-24-045720.md) | [54.2 d](/filings/0001140361-26-005130.md) | [3.3](/filings/0001140361-25-018024.md) | [51.2 d](/filings/0001140361-25-029673.md) | [31.4 d](/filings/0001140361-25-040839.md) | [25.8 d](/filings/0001140361-26-005130.md) | [0.4](/filings/0001140361-26-019630.md) | [35.8 d](/filings/0001140361-26-032055.md) | [27.5 d](/filings/0001140361-25-040839.md) | [16.6 d](/filings/0001140361-26-005130.md) | [(3.9)](/filings/0001140361-26-019630.md) | [10.6 d](/filings/0001140361-26-032055.md) |
| Capital expenditure | $m | [11.9 d](/filings/0001140361-24-045720.md) | [20.4 d](/filings/0001140361-26-005130.md) | [12.3](/filings/0001140361-25-018024.md) | [8.1 d](/filings/0001140361-25-029673.md) | [8.6 d](/filings/0001140361-25-040839.md) | [12.6 d](/filings/0001140361-26-005130.md) | [13.6](/filings/0001140361-26-019630.md) | [0.0 d](/filings/0001140361-26-032055.md) | [9.9 d](/filings/0001140361-25-040839.md) | [10.8 d](/filings/0001140361-26-005130.md) | [13.7](/filings/0001140361-26-019630.md) | [5.6 d](/filings/0001140361-26-032055.md) |
| Dividends paid | $m | [19.5 d](/filings/0001140361-24-045720.md) | [19.3 d](/filings/0001140361-26-005130.md) | [3.0](/filings/0001140361-25-018024.md) | [3.0 d](/filings/0001140361-25-029673.md) | [3.0 d](/filings/0001140361-25-040839.md) | [3.0 d](/filings/0001140361-26-005130.md) | [3.0](/filings/0001140361-26-019630.md) | [3.0 d](/filings/0001140361-26-032055.md) | [3.0 d](/filings/0001140361-25-040839.md) | [2.9 d](/filings/0001140361-26-005130.md) | [2.9](/filings/0001140361-26-019630.md) | [2.9 d](/filings/0001140361-26-032055.md) |
| Share repurchases | $m | [13.0 d](/filings/0001140361-24-045720.md) | [0.0 d](/filings/0001140361-26-005130.md) | [0.0](/filings/0001140361-25-018024.md) | [0.0 d](/filings/0001140361-25-029673.md) | [0.0 d](/filings/0001140361-25-040839.md) | [0.0 d](/filings/0001140361-26-005130.md) | [5.0](/filings/0001140361-26-019630.md) | [0.0 d](/filings/0001140361-26-032055.md) | [5.0 d](/filings/0001140361-25-040839.md) | [10.0 d](/filings/0001140361-26-005130.md) | [5.0](/filings/0001140361-26-019630.md) | [0.0 d](/filings/0001140361-26-032055.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [50.2](/filings/0001140361-23-050921.md) | [50.1](/filings/0001140361-24-025012.md) | [50.2](/filings/0001140361-24-036467.md) | [49.9](/filings/0001140361-24-045720.md) | [49.5](/filings/0001140361-25-018024.md) | [49.7](/filings/0001140361-25-029673.md) | [49.7](/filings/0001140361-25-040839.md) | [50.3](/filings/0001140361-26-019630.md) | [49.5](/filings/0001140361-26-032055.md) | [50.3](/filings/0001140361-25-040839.md) | [49.4](/filings/0001140361-26-019630.md) | [48.6](/filings/0001140361-26-032055.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 48,676,634 at 2026-07-31, from the cover of the [10-Q filed 2026-08-10](/filings/0001140361-26-032055.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.